Seloxium advised by Penningtons Manches Cooper on spin-out from Oxford Uni
Seloxium, a new company developing methods to extract valuable metals from waste, has been advised on its spin-out from Oxford University and seed fundraising by the corporate team at Penningtons Manches Cooper.
Seloxium is currently working on a ‘selective flocculation’ technology named Selectal™. Selective flocculation is a process of extracting desired substances – Seloxium’s technology helps business obtain high-purity metals from their waste or process streams.
Dr Christian Peters, a co-founder, and Seloxium’s chief executive officer said: “I am very excited that Seloxium is helping change the way we reclaim, process and recycle critically important metals in a more efficient and environmentally responsible way. I’m grateful to James Went and the Penningtons Manches Cooper team for their help in this important step forward for Seloxium.”
Read more - Oxford’s Quorbit acquired by US tech company
Along with extraction, the process also contributes to a company’s ESG goals by removing toxic metals from its wastewater.
The company’s recent seed funding round was led by Oxford Science Enterprises in cooperation with Oxford University’s technology transfer office, Oxford University Innovation.
Corporate Partner James Went led the Penningtons Manches Cooper team advising Seloxium with corporate senior associate Lindsay Chadwick. They were supported by IP partner Chris Shelley, commercial managing associate Edmund Forey and employment senior associate Victoria Spires.
James Went, corporate partner at Penningtons Manches Cooper said: “We are delighted to have advised Seloxium on their spin-out from Oxford University and initial seed funding. Their work is addressing critical environmental challenges and we look forward to continuing to support them on their journey.”
Read more - Native Antigen Company expands its range of Omicron Antigens
Featured image: Seloxium
